UNSPSC 51263173: Timolol anhydrous

This classification denotes a beta-adrenergic blocking agent with the molecular formula C13H24N4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5JKY92S7BR. The term TIMOLOL ANHYDROUS is an International Non-Proprietary Name or INN. Most nations, for tariff and trade purposes, schedule timolol anhydrous under HS 29349990. As of Q4 2014, TIMOLOL ANHYDROUS remains US FDA's Preferred Term for this commodity. Timolol anhydrous bears US NLM identifiers UMLS ID C2983887 and NCI Concept Code C90802.

SMILES: CC(C)(C)NC[C@@H](COC1C(NSN1)N2CCOCC2)O.

UNSPSC 51263173 Timolol anhydrous, a Commodity code, nominally covers pharmaceutical products, but the recent state and local procurement activity tagged to this code does not align with its scope — the single recent opportunity solicited naloxone and drug deactivation systems rather than timolol or ophthalmic pharmaceuticals. State and local governments procure pharmaceutical products through this family for medical and public-health use, but the available records show minimal relevant recent activity under the code's actual commodity definition. The issuing bodies that do procure under pharmaceutical-related codes in this segment tend to include county health departments, public hospitals, and municipal community health agencies, though the present dataset does not support a characterization of repeat buyers or a broad issuing-body mix for this specific code.

Seminole County, Florida posted the sole recent opportunity on record — IFB 60459723LAS, a competitive invitation for bid issued June 30, 2026, for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The response deadline was July 26, 2023, and the contract structure included a two-year initial term with a one-year renewal option. However, this solicitation represents a material mismatch with the code's nominal scope, suggesting either a tagging error or minimal current activity in timolol procurement through state and local channels. Geographic concentration cannot be reliably assessed from a single misaligned opportunity.